Nurse Practitioner in Marblehead, OH Accepting Medicare
2 Nurse Practitioner nurses found. Showing 1 - 2
 Allison Lea Holzaepfel, C.N.P. Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 9451 E Harbor Rd, Marblehead, OH 43440 Phone: 419-798-4081 Fax: 418-798-2261 |
Stephanie Marie Scherger Gonya, CNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1297 W Main St, Marblehead, OH 43440 Phone: 419-798-4418 Fax: 419-798-4442 |
News Archive
Expert suggests ways to control uncomfortable vaginal symptoms in diabetic women
With approximately 9.7 million women in the U.S. suffering with diabetes and almost 50 million U.S. adults with prediabetes, most of the women are experiencing uncomfortable vaginal symptoms like recurrent yeast and bacterial infections, vaginal dryness, reduced sexual interest, and painful intercourse that can adversely affect quality of life.
Graphene Flagship project studies impact of graphene and related materials on our health
As the drive to commercialize graphene continues, it is important that all safety aspects are thoroughly researched and understood.
Blood vessel cells are instructed to form tube-like structures
How do blood vessel cells understand that they should organise themselves in tubes and not in layers? A research group from Uppsala University shows for the first time that a special type of "instructor" molecule is needed to accomplish this. These findings, published in the scientific journal Blood, might be an important step towards using stem cells to build new organs.
Trump administration rule would undo health care protections for LGBTQ patients
A new Trump administration proposal would change the civil rights rules dictating whether providers must care for patients who are transgender or have had an abortion. Supporters of the approach say it protects the freedom of conscience, but opponents say it encourages discrimination.
OXiGENE reports consolidated net loss of $11.0M for first-quarter 2010
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, reported financial results for the quarter ended March 31, 2010, and presented an update on recent clinical and corporate progress.
› Verified 1 days ago